CXM

2.56%

3.8¢ centrex limited

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-18

First 18 Last

Share
Profile

Follow
stompers

328 Posts.

36

31/10/23

12:19

Post #: 70638319
Share

Originally posted by fup: ↑

still dont understand why they didnt raise when this was above 15c. could've equity funded the whole thing to stage 1.5 and not have to worry about the cost of production, sourcing debt etc. obviously these guys are considering their own position as large shareholders and not having enough money to tip in or diluting themselves out. instead we get dragged along for the ride (or die) to debt financing land. if i was in the country for the agm i would absolutely be asking them what the hell they were thinking
the EFA facility only got extended for 6 months to march, seems weird to only go for such a short time unless they were expecting to get a larger facility by then. i'm sure it would only be secured against trade receivables which is why the rate is so high, this security would be a pretty standard carve out by way of intercreditor deed with another lender for the project financing, it's not a big deal, i'm more curious about the length / timing. the fact that the facility limit is pretty much the same limit as previous means it's been rolled over to a longer maturity. if they were forcing cxm to repay they wouldn't have extended it or adjusted the limit to = the outstanding balance.

if u believe the report that next quarter's sales will be 40,000t at $327AUD as calculated by LD99 then that's $13 million, a big number notwithstanding most of it will be eaten by operating and production costs, still not getting close the the world bank price and the company needs to explain why this is the case.

Expand

They might of extended it because the alternative is to wind up the company and write off the debt. I'm doubtful achieving scale will solve their problems as a big portion of the cost is variable and can't be solved without a bulk transport solution. No doubt the lenders are reviewing the financials and the trigger for an uplift will be obtaining debt finance.

CXM Price at posting: 6.3¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 3 more messages in this thread...

First 18 Last

Add CXM (ASX) to my watchlist

(20min delay)
Last 3.8¢		Change -0.001(2.56%)		Mkt cap ! $32.91M

Open	High	Low	Value	Volume
3.9¢	3.9¢	3.6¢	$30.32K	814.5K

Buyers (Bids)

No.	Vol.	Price($)
1	1600	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.9¢	3229	1

View Market Depth

No.	Vol.	Price($)
1	250000	0.037
2	197619	0.036
3	152329	0.035
2	63383	0.034
2	180333	0.033

Price($)	Vol.	No.
0.039	3229	1
0.040	403817	3
0.041	19973	1
0.042	98833	2
0.043	385739	2

Last trade - 15.34pm 04/10/2024 (20 minute delay)

CXM (ASX) Chart

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-18

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-18

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News